Europe — EMA
Lamivudina E Zidovudina Mylan
GNH USA supplies Lamivudina E Zidovudina Mylan (Zidovudine/Lamivudine), a nucleoside reverse transcriptase inhibitor for HIV-1 infection and AIDS.
Request sourcing
What is Zidovudine, Lamivudine?
Zidovudine, the active ingredient in Lamivudina E Zidovudina Mylan, is a nucleoside reverse transcriptase inhibitor presented as an oral tablet for oral use. It is used to treat HIV-1 infection and AIDS in adults and children. GNH USA supplies Lamivudina E Zidovudina Mylan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Zidovudine, Lamivudine used for?
Lamivudina E Zidovudina Mylan is an antiretroviral medication used in the management of HIV infection and related conditions. - HIV-1 infection: reduces viral load and helps restore immune function. - AIDS: slows disease progression and decreases opportunistic infections. - Prevention of mother‑to‑child transmission: lowers the risk of HIV transmission from mother to infant during pregnancy, delivery, or breastfeeding.
What are the side effects of Zidovudine, Lamivudine?
Adverse reactions may occur with Lamivudina E Zidovudina Mylan and are categorized by frequency and severity.
Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: transient cranial discomfort. - Fatigue: generalized tiredness. - Anemia: reduced red blood cell count causing pallor.
Serious or Rare Side Effects: - Severe lactic acidosis: buildup of lactic acid requiring urgent care. - Hepatic steatosis: fatty changes in the liver that may impair function. - Bone marrow suppression: marked decrease in blood cell production leading to infection risk.
What precautions apply to Zidovudine, Lamivudine?
Before using Lamivudina E Zidovudina Mylan, consider the following safety measures. - Pregnancy: Category C; discuss risks with a healthcare professional. - Breastfeeding: Evaluate benefits versus potential infant exposure. - Liver disease: Monitor hepatic function regularly. - Hematologic disorders: Conduct baseline and periodic blood counts. - Store at ambient temperature: keep below 25 °C in the original packaging, protect from moisture.
What does Zidovudine, Lamivudine interact with?
Lamivudina E Zidovudina Mylan may interact with other medicines, altering efficacy or safety.
Major Interactions (Avoid): - Didanosine: increased risk of peripheral neuropathy. - Stavudine: heightened mitochondrial toxicity. - Certain protease inhibitors: may elevate zidovudine plasma levels.
Moderate Interactions (Monitor Closely): - Trimethoprim‑sulfamethoxazole: potential for additive bone marrow suppression. - Non‑nucleoside reverse transcriptase inhibitors: may require dose adjustment.
Frequently asked questions
What is Lamivudina E Zidovudina Mylan used for?+
How does zidovudine work in this product?+
What is the usual dose of Lamivudina E Zidovudina Mylan?+
Is Lamivudina E Zidovudina Mylan safe during pregnancy or breastfeeding?+
How do I order Lamivudina E Zidovudina Mylan from GNH USA?+
How does this combination compare with other antiretroviral options?+
What are the storage requirements for Lamivudina E Zidovudina Mylan?+
How is Lamivudina E Zidovudina Mylan administered?+
What are the most serious risks associated with this medication?+
Who should not use Lamivudina E Zidovudina Mylan?+
Product details
Related products

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo